Association between iron deficieny and vaccine response to parental SARS-CoV 2 in cardiovascular high-risk patients

Association between iron deficieny and vaccine response to parental SARS-CoV 2 in cardiovascular high-risk patients - HOMe FerVac

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00030558

Enrollment

Registered

2022-10-24

Start date

2022-08-02

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

E61.1

Interventions

Group 1: - Detection of SARS-CoV-2 IgG antibodies (ELISA) not longer than 14 days previous to the 4 th vaccination + medical history + examination + echocardiography - detection of SARS-CoV-2 specific

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: - 4 th SARS CoV 2 vaccination is already dated - known heart failure or Framingham risk score (2008) > 15 %

Exclusion criteria

Exclusion criteria: - pregnancy or nursing - ESA treatment or intravenous iron application or application of red blood cell concentrate in the last 60 days before the vaccination - current chemotherapy or radiatio

Design outcomes

Primary

Measure	Time frame
Difference between levels of SARS-CoV 2 specific T cells day 13 to day 18 after vaccination	—

Secondary

Measure	Time frame
no secondary endpoint	—

Countries

Germany

Contacts

Public ContactInsa Emrich

Universitätsklinikum des SaarlandesKlinik für Innere Medizin III

insa.emrich@uks.eu06841 - 16 51948

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026